Profile data is unavailable for this security.
About the company
Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.
- Revenue in CAD (TTM)1.84bn
- Net income in CAD-322.81m
- Incorporated2014
- Employees5.65k
- LocationCuraleaf Holdings Inc420 Lexington AvenueNEW YORK 10170United StatesUSA
- Phone+1 (781) 451-0117
- Websitehttps://ir.curaleaf.com/
Mergers & acquisitions
Acquired company | CURA:TOR since announced | Transaction value |
---|---|---|
Northern Green Canada Inc | -9.74% | -- |
Cronos Group Inc | 40.63% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. | 577.13m | -200.43m | 3.96bn | 517.00 | -- | 22.21 | -- | 6.85 | -0.493 | -0.493 | 1.42 | 0.4413 | 0.5955 | 1.00 | 5.86 | 819,127.70 | -20.68 | -30.65 | -25.76 | -36.55 | 89.62 | 88.94 | -34.73 | -86.10 | 2.61 | -1.36 | 0.7482 | -- | 21.30 | 34.35 | 35.92 | -- | 3.36 | -- |
SpringWorks Therapeutics Inc | 36.05m | -462.08m | 4.19bn | 305.00 | -- | 5.41 | -- | 116.12 | -5.15 | -5.15 | 0.4007 | 7.66 | 0.0432 | -- | -- | 86,731.15 | -55.31 | -36.97 | -60.58 | -39.49 | 93.86 | -- | -1,281.78 | -2,176.46 | 6.77 | -- | 0.00 | -- | -- | -- | -17.19 | -- | 90.68 | -- |
Biohaven Ltd | 0.00 | -704.81m | 4.22bn | 239.00 | -- | 9.53 | -- | -- | -6.83 | -6.83 | 0.00 | 3.68 | 0.00 | -- | -- | 0.00 | -99.74 | -- | -123.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.43 | -- | -- | -- |
Dyne Therapeutics Inc | 0.00 | -350.78m | 4.24bn | 143.00 | -- | 5.81 | -- | -- | -3.97 | -3.97 | 0.00 | 5.49 | 0.00 | -- | -- | 0.00 | -63.48 | -52.81 | -67.12 | -57.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.36 | -- | 40.32 | -- |
Corcept Therapeutics Incorporated | 713.47m | 160.84m | 4.28bn | 352.00 | 28.22 | 5.73 | 26.39 | 6.00 | 1.07 | 1.07 | 4.74 | 5.27 | 0.822 | 1.12 | 11.13 | 1,487,298.00 | 18.53 | 21.17 | 21.50 | 23.85 | 98.54 | 98.52 | 22.54 | 27.23 | 5.10 | -- | 0.00 | 0.00 | 20.04 | 13.93 | 4.66 | 7.08 | -14.15 | -- |
Guardant Health Inc | 822.76m | -628.12m | 4.52bn | 1.78k | -- | 48.33 | -- | 5.49 | -3.92 | -3.92 | 5.17 | 0.5607 | 0.3754 | 4.37 | 7.03 | 339,362.00 | -28.66 | -22.26 | -33.02 | -24.59 | 60.37 | 64.62 | -76.34 | -97.07 | 5.66 | -59.55 | 0.9435 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
Ultragenyx Pharmaceutical Inc | 603.16m | -835.87m | 4.55bn | 1.28k | -- | 23.78 | -- | 7.54 | -8.02 | -8.02 | 5.75 | 1.69 | 0.329 | 1.61 | 6.18 | 346,854.20 | -45.59 | -33.35 | -55.09 | -38.30 | 88.59 | 93.13 | -138.58 | -154.71 | 2.28 | -- | 0.00 | -- | 19.52 | 53.18 | 14.25 | -- | 62.91 | -- |
Curaleaf Holdings Inc | 1.84bn | -322.81m | 4.67bn | 5.65k | -- | 3.35 | -- | 2.53 | -0.4423 | -0.514 | 2.53 | 1.88 | 0.4198 | 3.07 | 24.81 | 326,282.20 | -7.65 | -7.38 | -9.75 | -8.67 | 45.45 | 43.30 | -18.23 | -18.12 | 0.3579 | 0.3536 | 0.4585 | -- | 5.58 | 77.21 | 11.09 | -- | 8.92 | -- |
Axsome Therapeutics Inc | 342.09m | -403.90m | 4.75bn | 545.00 | -- | 24.20 | -- | 13.89 | -6.38 | -6.38 | 5.41 | 3.03 | 0.537 | 2.11 | 3.43 | 460,592.70 | -63.40 | -64.55 | -85.88 | -82.23 | 90.12 | -- | -118.07 | -227.05 | 3.09 | -55.54 | 0.556 | -- | 440.80 | -- | -27.84 | -- | 77.86 | -- |
Crinetics Pharmaceuticals Inc | 2.69m | -320.89m | 4.77bn | 290.00 | -- | 3.99 | -- | 1,774.14 | -3.77 | -3.77 | 0.0315 | 11.14 | 0.0031 | -- | 0.3653 | 6,806.90 | -35.57 | -42.53 | -37.86 | -45.36 | -- | -- | -11,641.13 | -5,446.39 | -- | -- | 0.00 | -- | -15.28 | 10.57 | -30.88 | -- | 34.65 | -- |
Merus NV | 52.25m | -203.95m | 4.89bn | 172.00 | -- | 8.94 | -- | 93.56 | -2.72 | -2.72 | 0.7031 | 5.95 | 0.0917 | -- | 1.21 | 222,889.50 | -35.78 | -29.35 | -43.82 | -35.36 | -- | -- | -390.36 | -252.21 | -- | -- | 0.00 | -- | 5.68 | 2.75 | -18.10 | -- | -1.73 | -- |
Immunovant Inc | 0.00 | -353.42m | 5.05bn | 207.00 | -- | 5.98 | -- | -- | -1.89 | -1.89 | 0.00 | 4.24 | 0.00 | -- | -- | 0.00 | -48.37 | -- | -52.91 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -22.93 | -- | -- | -- |
Simply Good Foods Co | 1.73bn | 191.82m | 5.24bn | 271.00 | 27.63 | 2.34 | 23.77 | 3.04 | 1.39 | 1.39 | 12.53 | 16.48 | 0.5977 | 6.91 | 8.56 | 4,671,908.00 | 6.65 | 3.66 | 6.95 | 3.83 | 37.26 | 38.90 | 11.12 | 6.80 | 3.09 | 9.26 | 0.1261 | 0.00 | 6.33 | 23.56 | 23.03 | 13.65 | 47.09 | -- |
Alkermes Plc | 2.35bn | 817.61m | 5.40bn | 2.10k | 6.68 | 3.16 | 5.96 | 2.29 | 3.50 | 2.53 | 10.05 | 7.42 | 0.8532 | 1.32 | 5.81 | 821,991.40 | 29.65 | 1.34 | 38.77 | 1.74 | 85.31 | 83.32 | 34.76 | 2.12 | 2.77 | -- | 0.1878 | 0.00 | 49.61 | 8.74 | 1,665.99 | -- | -7.10 | -- |
Holder | Shares | % Held |
---|---|---|
AdvisorShares Investments LLCas of 10 May 2024 | 10.18m | 1.59% |
Tidal Investments LLCas of 09 May 2024 | 4.97m | 0.77% |
Mackenzie Financial Corp.as of 09 May 2024 | 1.57m | 0.25% |
Putnam Investment Management LLCas of 28 Mar 2024 | 838.50k | 0.13% |
Penserra Capital Management LLCas of 09 May 2024 | 704.20k | 0.11% |
Picton Mahoney Asset Managementas of 31 Dec 2023 | 292.90k | 0.05% |
TD Asset Management, Inc.as of 10 May 2024 | 243.42k | 0.04% |
Baader Bank AG (Investment Management)as of 30 Apr 2024 | 163.00k | 0.03% |
Friedberg Advisors LPas of 30 Jun 2023 | 136.89k | 0.02% |
Albert D. Mason, Inc.as of 31 Mar 2024 | 87.99k | 0.01% |